How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
Pedro Póvoa(University of Lisbon), André C. Kalil(Nebraska Medical Center), Ricard Ferrer(Universitat Autònoma de Barcelona), Grant Waterer(The University of Western Australia), Anahita Rouzé(Centre Hospitalier Universitaire de Lille), Andrew Conway Morris(Cambridge University Hospitals NHS Foundation Trust), Luís Coelho(University of Lisbon), Daniel A. Sweeney(University of California System), Angela Huttner(University Hospital of Geneva), Jorge I. Salluh(Universidade Federal do Rio de Janeiro), Paula Ramírez(Hospital Universitari i Politècnic La Fe), Felipe Dal‐Pizzol(Universidade do Sul de Santa Catarina), Vandack Nobre(Universidade Federal de Minas Gerais), Antoní Torres(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Mervyn Singer(Bury College)
Cited by 293
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k